Bonesupport reported some very promising results in the latest report, but the market has not yet, in my opinion, realised its value. It actually gave no effect at all on the stock.
ABG sundal Collier recently raised the target price to 53kr from 30kr.
ABG Sundal Collier höjer riktkursen för Bonesupport till 53 kronor från 30 kronor. Rekommendationen köp...
